Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study.

B G Durie; J Crowley; C A Coltman; R A Chapman; S P Balcerzk; J D Bonnet; D A Lipschitz; R L Stephens; B D Cheson

doi:10.1007/BF00183574

Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study.

Identifier:nobleid.org/w1/20260515/19D4100F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/19D4100F.svg?ark=w1%2F20260515%2F19D4100F)](https://nobleid.org/work/w1/20260515/19D4100F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study.

Identifier:nobleid.org/w1/20260515/19D4100F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/19D4100F.svg?ark=w1%2F20260515%2F19D4100F)](https://nobleid.org/work/w1/20260515/19D4100F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work